Protein ligand interactions:isoquinoline alkaloids as inhibitors for lactate and malate dehydrogenase
- PMID: 2037868
- DOI: 10.3109/14756369109035847
Protein ligand interactions:isoquinoline alkaloids as inhibitors for lactate and malate dehydrogenase
Abstract
Kinetic analysis has shown that isoquinoline, papaverine and berberine act as reversible competitive inhibitors to muscle lactate dehydrogenase and mitochondrial malate dehydrogenase with respect to the coenzyme NADH. The inhibitor constants Ki vary from 7.5 microM and 12.6 microM berberine interaction with malate dehydrogenase and lactate dehydrogenase respectively to 91.4 microM and 196.4 microM with papaverine action on these two enzymes. Isoquinoline was a poor inhibitor with Ki values of 200 microM (MDH) to 425 microM (LDH). No inhibition was observed for both enzymes in terms of their respective second substrate (oxaloacetic acid - malate dehydrogenase; pyruvate - lactate dehydrogenase). A fluorimetric analysis of the binding of the three alkaloids show that the dissociation constants (Kd) for malate dehydrogenase are 2.8 microM (berberine), 46 microM (papaverine) and 86 microM (isoquinoline); the corresponding values for lactate dehydrogenase are 3.1 microM, 52 microM and 114 microM. In all cases the number of binding sites averaged at 2 (MDH) and 4 (LDH). The binding of the alkaloids takes place at sites close to the coenzyme binding site. No conformational non equivalence of subunits is evident.
Similar articles
-
Protein ligand interactions. Part 5: Isoquinoline alkaloids as inhibitors of acetylcholinesterase from Electrophorus electricus.J Enzyme Inhib. 1995;9(4):285-94. doi: 10.3109/14756369509036557. J Enzyme Inhib. 1995. PMID: 8598538
-
Onchocerca volvulus: effect of suramin on lactate dehydrogenase and malate dehydrogenase.Tropenmed Parasitol. 1980 Mar;31(1):55-8. Tropenmed Parasitol. 1980. PMID: 7376252
-
Inhibition kinetics of NAD-linked enzymes by gossypol acetic acid.Andrologia. 1990 Sep-Oct;22(5):409-16. doi: 10.1111/j.1439-0272.1990.tb02019.x. Andrologia. 1990. PMID: 2073051
-
Alkaloids as aldose reductase inhibitors, with special reference to berberine.J Altern Complement Med. 2014 Mar;20(3):195-205. doi: 10.1089/acm.2013.0088. Epub 2013 Nov 15. J Altern Complement Med. 2014. PMID: 24236461 Review.
-
Lactate dehydrogenase and malate dehydrogenase: Potential antiparasitic targets for drug development studies.Bioorg Med Chem. 2021 Nov 15;50:116458. doi: 10.1016/j.bmc.2021.116458. Epub 2021 Oct 9. Bioorg Med Chem. 2021. PMID: 34687983 Review.
Cited by
-
Natural compounds as lactate dehydrogenase inhibitors: potential therapeutics for lactate dehydrogenase inhibitors-related diseases.Front Pharmacol. 2023 Oct 17;14:1275000. doi: 10.3389/fphar.2023.1275000. eCollection 2023. Front Pharmacol. 2023. PMID: 37915411 Free PMC article. Review.
-
Natural products targeting human lactate dehydrogenases for cancer therapy: A mini review.Front Chem. 2022 Sep 29;10:1013670. doi: 10.3389/fchem.2022.1013670. eCollection 2022. Front Chem. 2022. PMID: 36247675 Free PMC article. Review.
-
Optimization of a non-radioactive high-throughput assay for decarboxylase enzymes.Assay Drug Dev Technol. 2010 Apr;8(2):175-85. doi: 10.1089/adt.2009.0249. Assay Drug Dev Technol. 2010. PMID: 20085486 Free PMC article.